Skip to main content
. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112

Table 1. Metaregression of weight changes per period.

Period aripiprazole asenapine clozapine FGA haloperidol olanzapine quetiapine risperidone ziprasidone placebo
≤6 wk* 0 0 0 0 0 0 0 0 0 0
6–16 wk −0.46 −1.78–0.85 −2.37 −6.93–2.19 −2.19 −6.63–2.25 −0.25 −2.50–1.99 0.472 −0.16–1.60 0.05 −1.26–1.36 −0.58 −1.57–0.72 −0.97 −3.08–1.13 0.25 −0.14–0.64
16–38 wk −1.43 −2.75–−0.12 −1.25 −5.98–3.48 −3.81 −8.18–0.55 2.75 −0.58–6.08 0.26−0.68–1.20 −0.54−1.94–0.86 −0,03 −1.03–0.96 −1.68 −3.78–0.41 −0.26 −0.81–0.28
>38 wk −0.20 −1.64–1.24 0.74 −3.24–4.72 1.09 −3.47–5.66 2.79 −1.12–6.70 1.81 −0.53–4.15 1.74 0.50–2.99 −0.85 −2.56–0.87 0.37 −0.63–1.38 −0.50 −3.67–2.68 −1.08 −1.88–−0.29

The coeffecient indicates the changes of weight compared with the constant (period 1).

* period 1 (≤6 wk) is the reference category.

Data in italics indicate 95% confidence interval.

The data in bold indicate significant difference in weight change of reference category.